Market Research Logo

Acute Coronary Syndrome

Acute Coronary Syndrome

Acute Coronary Syndrome market worldwide is projected to grow by US$37.2 Billion, driven by a compounded growth of 13.3%. Acute Coronary Syndrome, one of the segments analyzed and sized in this study, displays the potential to grow at over 13.3%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$63.8 Billion by the year 2025, Acute Coronary Syndrome will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 11.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$1.5 Billion to the region's size and clout in the next 5 to 6 years. Over US$1.2 Billion worth of projected demand in the region will come from Rest of Europe markets. In Japan, Acute Coronary Syndrome will reach a market size of US$3.5 Billion by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 17.1% over the next couple of years and add approximately US$9 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include among others, Amgen, Inc.; Astellas Pharma, Inc.; AstraZeneca PLC; Biological E. Ltd.; Daiichi Sankyo Co., Ltd.; Dr. Reddy's Laboratories Ltd.; Eisai Co., Ltd.; Eli Lilly and Company; F. Hoffmann-La Roche AG; GlaxoSmithKline PLC; Johnson & Johnson; Momenta Pharmaceuticals, Inc.; Pfizer, Inc.; Recordati SpA; The Medicines Company

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Acute Coronary Syndrome Competitor Market Share Scenario Worldwide (in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Acute Coronary Syndrome Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 2: Acute Coronary Syndrome Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
TABLE 3: Acute Coronary Syndrome Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
TABLE 4: United States Acute Coronary Syndrome Market Estimates and Projections in US$ Million: 2018 to 2025
TABLE 5: Acute Coronary Syndrome Market in the United States: A Historic Review in US$ Million for 2009-2017
CANADA
TABLE 6: Canadian Acute Coronary Syndrome Market Estimates and Forecasts in US$ Million: 2018 to 2025
TABLE 7: Canadian Acute Coronary Syndrome Historic Market Review in US$ Million: 2009-2017
JAPAN
TABLE 8: Japanese Market for Acute Coronary Syndrome: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 9: Acute Coronary Syndrome Market in Japan: Historic Sales Analysis in US$ Million for the Period 2009-2017
CHINA
TABLE 10: Chinese Acute Coronary Syndrome Market Growth Prospects in US$ Million for the Period 2018-2025
TABLE 11: Acute Coronary Syndrome Historic Market Analysis in China in US$ Million: 2009-2017
EUROPE
Market Facts & Figures
TABLE 12: European Acute Coronary Syndrome Market Demand Scenario in US$ Million by Region/Country: 2018-2025
TABLE 13: Acute Coronary Syndrome Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
TABLE 14: European Acute Coronary Syndrome Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
FRANCE
TABLE 15: Acute Coronary Syndrome Market in France: Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 16: French Acute Coronary Syndrome Historic Market Scenario in US$ Million: 2009-2017
GERMANY
TABLE 17: Acute Coronary Syndrome Market in Germany: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
TABLE 18: German Acute Coronary Syndrome Historic Market Analysis in US$ Million: 2009-2017
ITALY
TABLE 19: Italian Acute Coronary Syndrome Market Growth Prospects in US$ Million for the Period 2018-2025
TABLE 20: Acute Coronary Syndrome Historic Market Analysis in Italy in US$ Million: 2009-2017
UNITED KINGDOM
TABLE 21: United Kingdom Market for Acute Coronary Syndrome: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 22: Acute Coronary Syndrome Market in the United Kingdom: Historic Sales Analysis in US$ Million for the Period 2009-2017
SPAIN
TABLE 23: Spanish Acute Coronary Syndrome Market Estimates and Forecasts in US$ Million: 2018 to 2025
TABLE 24: Spanish Acute Coronary Syndrome Historic Market Review in US$ Million: 2009-2017
RUSSIA
TABLE 25: Russian Acute Coronary Syndrome Market Estimates and Projections in US$ Million: 2018 to 2025
TABLE 26: Acute Coronary Syndrome Market in Russia: A Historic Review in US$ Million for 2009-2017
REST OF EUROPE
TABLE 27: Rest of Europe Acute Coronary Syndrome Market Estimates and Forecasts in US$ Million: 2018-2025
TABLE 28: Acute Coronary Syndrome Market in Rest of Europe in US$ Million: A Historic Review for the Period 2009-2017
ASIA-PACIFIC
TABLE 29: Asia-Pacific Acute Coronary Syndrome Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 30: Acute Coronary Syndrome Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
TABLE 31: Asia-Pacific Acute Coronary Syndrome Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
AUSTRALIA
TABLE 32: Acute Coronary Syndrome Market in Australia: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
TABLE 33: Australian Acute Coronary Syndrome Historic Market Analysis in US$ Million: 2009-2017
INDIA
TABLE 34: Indian Acute Coronary Syndrome Market Estimates and Forecasts in US$ Million: 2018 to 2025
TABLE 35: Indian Acute Coronary Syndrome Historic Market Review in US$ Million: 2009-2017
SOUTH KOREA
TABLE 36: Acute Coronary Syndrome Market in South Korea: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
TABLE 37: South Korean Acute Coronary Syndrome Historic Market Analysis in US$ Million: 2009-2017
REST OF ASIA-PACIFIC
TABLE 38: Rest of Asia-Pacific Market for Acute Coronary Syndrome: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 39: Acute Coronary Syndrome Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million for the Period 2009-2017
LATIN AMERICA
TABLE 40: Latin American Acute Coronary Syndrome Market Trends by Region/Country in US$ Million: 2018-2025
TABLE 41: Acute Coronary Syndrome Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
TABLE 42: Latin American Acute Coronary Syndrome Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
ARGENTINA
TABLE 43: Argentinean Acute Coronary Syndrome Market Estimates and Forecasts in US$ Million: 2018-2025
TABLE 44: Acute Coronary Syndrome Market in Argentina in US$ Million: A Historic Review for the Period 2009-2017
BRAZIL
TABLE 45: Acute Coronary Syndrome Market in Brazil: Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 46: Brazilian Acute Coronary Syndrome Historic Market Scenario in US$ Million: 2009-2017
MEXICO
TABLE 47: Acute Coronary Syndrome Market in Mexico: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
TABLE 48: Mexican Acute Coronary Syndrome Historic Market Analysis in US$ Million: 2009-2017
REST OF LATIN AMERICA
TABLE 49: Rest of Latin America Acute Coronary Syndrome Market Estimates and Projections in US$ Million: 2018 to 2025
TABLE 50: Acute Coronary Syndrome Market in Rest of Latin America: A Historic Review in US$ Million for 2009-2017
MIDDLE EAST
TABLE 51: The Middle East Acute Coronary Syndrome Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 52: Acute Coronary Syndrome Market in the Middle East by Region/Country in US$ Million: 2009-2017
TABLE 53: The Middle East Acute Coronary Syndrome Market Share Breakdown by Region/Country: 2009, 2019, and 2025
IRAN
TABLE 54: Iranian Market for Acute Coronary Syndrome: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 55: Acute Coronary Syndrome Market in Iran: Historic Sales Analysis in US$ Million for the Period 2009-2017
ISRAEL
TABLE 56: Israeli Acute Coronary Syndrome Market Estimates and Forecasts in US$ Million: 2018-2025
TABLE 57: Acute Coronary Syndrome Market in Israel in US$ Million: A Historic Review for the Period 2009-2017
SAUDI ARABIA
TABLE 58: Saudi Arabian Acute Coronary Syndrome Market Growth Prospects in US$ Million for the Period 2018-2025
TABLE 59: Acute Coronary Syndrome Historic Market Analysis in Saudi Arabia in US$ Million: 2009-2017
UNITED ARAB EMIRATES
TABLE 60: Acute Coronary Syndrome Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
TABLE 61: United Arab Emirates Acute Coronary Syndrome Historic Market Analysis in US$ Million: 2009-2017
REST OF MIDDLE EAST
TABLE 62: Acute Coronary Syndrome Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
TABLE 63: Rest of Middle East Acute Coronary Syndrome Historic Market Analysis in US$ Million: 2009-2017
AFRICA
TABLE 64: African Acute Coronary Syndrome Market Estimates and Projections in US$ Million: 2018 to 2025
TABLE 65: Acute Coronary Syndrome Market in Africa: A Historic Review in US$ Million for 2009-2017
IV. COMPETITION
AMGEN
ASTELLAS PHARMA, INC.
ASTRAZENECA PLC
BIOLOGICAL E.
DAIICHI SANKYO CO., LTD.
DR. REDDY'S LABORATORIES LTD.
EISAI CO.
ELI LILLY AND COMPANY
F. HOFFMANN-LA ROCHE AG
GLAXOSMITHKLINE PLC
JOHNSON & JOHNSON
MOMENTA PHARMACEUTICALS
PFIZER, INC
RECORDATI SPA
THE MEDICINES COMPANY
V. CURATED RESEARCH

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook